NEW YORK, Sept. 5 (GenomeWeb News) - The National Institutes of Health announced today that it will commit $3 million in financial year 2004 to fund the use of genomic methods to track responses to drugs used to treat mood or anxiety disorders.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
